tldrdailynews.com logo

Eli Lilly's forforglipron Shows Promising Results in Weight Loss and Obesity Treatment

1 min read
Source: Reuters
Eli Lilly's forforglipron Shows Promising Results in Weight Loss and Obesity Treatment
Photo: Reuters
TL;DR

Eli Lilly's experimental oral GLP-1 pill, orforglipron, helped overweight adults with type 2 diabetes lose an average of 10.5% of their body weight in a late-stage trial, with significant improvements in blood sugar levels, positioning it as a promising alternative to injectable obesity drugs and potentially paving the way for regulatory approval and market launch next year.

Topics:businesshealth#glp-1-pill#health#lilly#orforglipron#type-2-diabetes#weight-loss
Share this article
  1. Lilly pill cuts body weight by 10.5% in patients with type 2 diabetes  Reuters
  2. Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval  CNBC
  3. Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity  Eli Lilly and Company
  4. Eli Lilly GLP-1 pill shows promising weight loss in type 2 diabetes trial  USA Today
  5. Eli Lilly Ready to Seek Obesity Pill Green Light After Study Hits Goals  The Wall Street Journal

Want the full story? Read the original reporting

Read on Reuters